Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis

Cladribine (CLAD) is a deoxyadenosine analogue prodrug which is given in multiple sclerosis (MS) as two short oral treatment courses 12 months apart.Reconstitution of adaptive immune function following selective immune cell depletion is the presumed mode of action.In this exploratory study, we investigated the impact of CLAD tablets on immune cell

read more